- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
PD‐1 blocking antibodies moonlighting as killers ; day:18 ; month:05 ; year:2021 ; extent:4
European journal of immunology ; (18.05.2021) (gesamt 4)
- Urheber
- DOI
-
10.1002/eji.202149276
- URN
-
urn:nbn:de:101:1-2021051915050086709653
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Leitner, Judith
- Battin, Claire
- Grabmeier‐Pfistershammer, Katharina
- Steinberger, Peter
Ähnliche Objekte (12)
Thyrotropin Receptor Blocking Antibodies
The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
Blocking Plasmodium development in the mosquitoes by human antibodies
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis
Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors
Thyroid blocking antibodies in autoimmune thyroid disease : = Schilddrüsenblockierende Autoantikörper in autoimmuner Schilddrüsenerkrankung
Turning antibodies off and on again using a covalently tethered blocking peptide
Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy
Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo
Thyrotropin Receptor Blocking Antibodies
The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
Blocking Plasmodium development in the mosquitoes by human antibodies
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis
Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors
Thyroid blocking antibodies in autoimmune thyroid disease : = Schilddrüsenblockierende Autoantikörper in autoimmuner Schilddrüsenerkrankung
Turning antibodies off and on again using a covalently tethered blocking peptide
Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy
Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo
Thyrotropin Receptor Blocking Antibodies
The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
Blocking Plasmodium development in the mosquitoes by human antibodies
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis
Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors
Thyroid blocking antibodies in autoimmune thyroid disease : = Schilddrüsenblockierende Autoantikörper in autoimmuner Schilddrüsenerkrankung
Turning antibodies off and on again using a covalently tethered blocking peptide
Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy